Artificial Liver Support in the Third Millennium

References

• Ash S. R., Blake D. E., Carr D. J. Clinical effects of a sorbent suspension dialysis system in treatment of hepatic coma ((the Biologic DT)). Int. J. Artif. Organs 1992; 5(3)151–161
   Google Scholar
• Baquerizo A., Mhoyan A., Shirwan A. Xenobody response of patients with severe acute liver failure exposed to porcine antigens following treatment with a bioartificial liver. Trans. Proc. 1997; 29: 964–965
   PubMedGoogle Scholar
• Chamuleau R. A.F.M. Treatment of acute hepatic encephalopathy. Neth. J. Med. 1979; 22: 203–209
   PubMedGoogle Scholar
• Dixit G. G. The bioartificial liver: state of the art. Eur. J. Surg. 1998; 582(S)71–76
   Google Scholar
• Dixit V., Gitnick G. Transplantation of microencapsulated hepatocytes for liver function replacement. J. Biomater. Sci., Polym. Ed. 1995; 7(4)343–357
   PubMed Web of Science ®Google Scholar
• Donini A., Baccarani U., Lavaroni S., Cautero N., Degrassi A. Temporary neurological improvement after bioartificial liver treatment for acute on chronic failure. ASAIO J. 2000; 46(2)241
   Google Scholar
• Ellis A. J., Hughes R. D., Wendon J. A., Dunne J., Langley P. G., Kelly J. H., Gislason G. T., Sussman N. L., Williams R. Pilot‐‐controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 1996; 24: 1446–1451
   PubMed Web of Science ®Google Scholar
• Flendrig L. M., Chamuleau R.A.F. M., Maas M.A. W. In vivo evaluation of a novel bioartificial liver in rats with complete liver ischemia: treatment efficacy and species‐‐specific alpha GST as a first attempt to monitor hepatocyte viability. J. Hepatol. 1999a; 30(2)311–320
   PubMedGoogle Scholar
• Flendrig L. M., Calise F., Di Florio E., Mancini M. Significant improvement of survival time in pigs with complete liver ischemia treated with a novel bioartificial liver. Int. J. Artif. Organs 1999b; 22(10)701–709
   PubMedGoogle Scholar
• Flendrig L. M., La Soe J. W., Jörning G. G., Steenbeek A., Karlsen O. T., Bovée W.M.M. J., Ladiges N.C.J. J., Velde A. A., Chamuleau R.A.F. M. In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound non‐‐woven polyester matrix for hepatocyte culture as small aggregates. J. Hepatol. 1997; 26: 1379–1392
   PubMed Web of Science ®Google Scholar
• Gerlach J. C. Development of a hybrid liver support system: a review. Int. J. Artif. Organs 1996; 19: 645–654
   PubMedGoogle Scholar
• Jauregui H. O., Mullon C.J. P., Trenkler D., Naik S., Santangini H., Press P., Muller T. E., Solomon B. A. In vivo evaluation of a hollow fiber liver assist device. Hepatology 1995; 21: 460–469
   PubMedGoogle Scholar
• Kardassis D., Busse B., Kraemer M. R., Smith M. D., Neuhaus P., Gerlach J. C. Hemodynamic effects of therapy with a hybrid liver support system. ASAIO J. 1999; 45(2)201
   Google Scholar
• Kelly J. H., Koussayer T., He D., Sussman N. L. Assessment of an extracorporeal liver assist device in anhepatic dogs. Artif. Organs 1992; 16: 418–423
   PubMed Web of Science ®Google Scholar
• Kobayashi N., Fujiwara T., Westerman K., Inoue Y., Sakaguchi M., Noguchi H., Miyazaki M., Cai J., Tanaka N., Fox I. J., Leboulch P. Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science 2000; 287: 1258–1262
   PubMed Web of Science ®Google Scholar
• Kubota H., Reid L. M. Clonogenic hepatoblasts, common precursors for hepatocytic and biliary lineages, are lacking classical major histocompatibility complex class I antigen. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 12132–12137
   PubMed Web of Science ®Google Scholar
• Morimoto T., Matsushima M., Sowa N., Ide K., Sawanishi K. Plasma adsorption using bilirubin adsorbent materials as a treatment for patients with hepatic failure. Artif. Organs 1989; 13: 447–542
   PubMed Web of Science ®Google Scholar
• Naruse K., Nagashima I., Sakai Y., Harihara Y., Jiang G. X., Suzuki M., Muto T., Makuuchi M. Efficacy of a bioreactor filled with porcine hepatocytes immobilized on nonwoven fabric for ex vivo direct hemoperfusion treatment of liver failure in pigs. Artif. Organs 1998; 22(12)1031–1037
   PubMedGoogle Scholar
• Nyberg S. L., Hibbs J. R., Hardin J. A., Germer J. J., Persing D. H. Transfer of porcine endogenous retroviruses across hollow fiber membranes. Transplantation 1999; 67(9)1251–1255
   PubMedGoogle Scholar
• Nyberg S. L., Shatford R. A. Evaluation of a hepatocyte‐‐entrapment hollow fiber bioreactor: a potential bioartificial liver. Biotechnol. Bioeng. 1993; 41: 194–203
   PubMed Web of Science ®Google Scholar
• O'Grady J. G., Gimson A. E., O'Brien C. J. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988; 94: 1186–1192
   PubMed Web of Science ®Google Scholar
• Paradis K., Langford G., Long Z. Search for cross‐‐species transmission of porcine endogenous retrovirus in patients with living pig tissue. Science 1999; 285: 1236–1241
   PubMed Web of Science ®Google Scholar
• Patience C., Takeuchi Y., Weiss R. B. Infection of human cells by an endogenous retrovirus of pigs. Nature Med. 1997; 3: 282–286
   PubMed Web of Science ®Google Scholar
• Patzer J. F., Kramer D. J., Mazariegos G. V., Lopez‐‐Solis R. C., Giraldo M., Grogan T. A., Zhu Y., Fulmer M. L., Amiot B. P. Clinical safety evaluation of excorp medical, inc. Bioartificial liver support system ((BLSS)). ASAIO J. 2000; 46(2)241
   Google Scholar
• Pazzi P., Morsiani E., Muraca M., Vilei M. T., Rozga J., Demetriou A. A. Metabolic characterization of bioartificial liver: focus on bile production and excretion. Bioartificial Liver Support Systems. The Critical Issues, G. Crepaldi, A. A. Demetriou, M. Muraca. CIC Edizioni Internationali, Roma 1997; 42–47
   Google Scholar
• Riordan S. M., Williams R. Acute liver failure: targeted artificial and hepatocyte‐‐based support of liver regeneration and reversal of multiorgan failure [[Review]]. J. Hepatol. 2000; 32(S 1)63–76
   PubMedGoogle Scholar
• Rozga J., Holzman M. D., Ro M. S., Griffin D. W., Neuzil D. F., Giorgio T., Moscioni A. D., Demetriou A. A. Development of a hybrid bioartificial liver. Ann. Surg. 1993; 217: 502–515
   PubMed Web of Science ®Google Scholar
• Sheil A. G.R., Sun J., Mears D. C., Waring M., Woodman K., Johnston B., Horvat M., Watson J., Kuotalistras N., Wang L. Positive biochemical effects of a bioartificial liver supprt system ((BALSS)) in a porcine fulminant hepatic failure ((FHF)) model. Int. J. Artif. Organs 1998; 21: 43–48
   PubMedGoogle Scholar
• Sarkis R., Wen L., Honiger J. Intraperitoneal transplantation of isolated hepatocytes of the pig: the implantable bioartificial liver. Chirurgie 1998; 123: 41–46
   PubMedGoogle Scholar
• Sielaff T. D., Hu M. Y., Amiot B., Rollins M. D., Rao S., McGuire B., Bloomer J. R., Hu W. S., Cerra F. B. Gel‐‐entrapment bioartificial liver therapy in galactosamine hepatitis. J. Surg. Res. 1995; 59: 179–184
   PubMedGoogle Scholar
• Stange J., Mitzner S. R., Risler T., Erley C. M., Lauchart W., Goehl H., Klammt S. Molecular adsorbent recycling system ((MARS)): clinical results of a new membrane‐‐based blood purification system for bioartificial liver support. Artif. Organs 1999; 23: 319–330
   PubMed Web of Science ®Google Scholar
• Sussman N. L. Fulminant Hepatic Failure. Hepatology: A Textbook of Liver Disease3rd Ed., D. Zakim, T. D. Boyer. W.B. Saunders Company, Philadelphia, London, Sydney 1996; 618–650
   Google Scholar
• Sussman N. L., Gislason G. T., Kelly J. H. Extracorporeal liver support. Application to fulminant hepatic failure. J. Clin. Gastroenterol. 1994; 18(4)320–324
   PubMedGoogle Scholar
• Te Velde A. A., Flendrig L. M., Ladiges N.C.J. J., Chamuleau R.A.F. M. Possible immunological problems of bioartificial liver support. Int. J. Artif. Organs 1997; 20: 418–421
   PubMedGoogle Scholar
• Tygstrup N., Larson F., Hanson B. Treatment of acute liver failure by high volume plasmapheresis. In Acute Liver Failure, W. Lee, R. Williams. Cambridge university Press, Cambridge 1997; 267–277
   Google Scholar
• Uchino J., Tsuburya T., Kumagai F., Hase T., Hamada T., Komai T., Funatsu A., Hashimura K., Nakamura K., Kon T. A hybrid artificial liver composed of multiplated hepatocyte monolayers. ASAIO Trans. 1988; 34: 972–977
   PubMedGoogle Scholar
• Watanabe F. D., Mullon C.J. P., Hewitt W. R. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Ann. Surg. 1997; 225(5)484–494
   PubMed Web of Science ®Google Scholar